Beyond the BBB: Mapping the 2026 Milestone Year for Neuroscience.  As we move through Q1, all eyes in the neuroscience community are on April 5, 2026—the PDUFA target action date for tividenofusp alfa (DNL310). If approved, tividenofusp alfa will be a watershed moment: the first commercial validation of a Transport Vehicle (TV) enabled enzyme replacement […]